Feasibility Study of a Multi-Component Intervention for Black Men Who Have Sex With Men

NCT00951249 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1553

Last updated 2022-08-26

No results posted yet for this study

Summary

It has been estimated that black men who have sex with men (MSM) account for one quarter of all new HIV infections in the US annually, yet little prevention work has been directed towards this population. The purpose of this study is to research and potentially design a new and better way to try and slow the spread of HIV among black MSM.

Conditions

  • HIV Infections

Interventions

BEHAVIORAL

Referral of Partners

Referral of up to five sexual partners by index participants for enrollment into the study

BEHAVIORAL

Screening for STIs and counseling

Identification of STIs and treatment or referral for treatment, if applicable

BEHAVIORAL

Peer health care system navigators

HIV/STI treatment and other medical and social services

BEHAVIORAL

Enhanced counseling

Counseling and referral for care offered to participants for issues such as substance use and mental health

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH
  • National Institute on Drug Abuse (NIDA)

    collaborator NIH
  • National Institute of Mental Health (NIMH)

    collaborator NIH
  • National Institutes of Health (NIH)

    collaborator NIH
  • HIV Prevention Trials Network

    lead NETWORK

Principal Investigators

  • Beryl Koblin, PhD · New York Blood Center

  • Kenneth Mayer, MD · Fenway Community Health Center

  • Darrell P. Wheeler, PhD, MPH, ACSW · School of Social Work, Hunter College

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00951249 on ClinicalTrials.gov